Invention Application
![Pyrido-[2,3-D] Pyrimidines and Their Use as Kinase Inhibitors](/docs/US/2014-06-12/US20140163005A1/abs.jpg.600x600.jpg)
- Patent Title: Pyrido-[2,3-D] Pyrimidines and Their Use as Kinase Inhibitors
-
Application No.: US13949666Application Date: 2013-07-24
-
Publication No.: US20140163005A1Publication Date: 2014-06-12
- Inventor: KRISHNA MURTHI , REBECCA CASAUBON , ARTHUR F. KLUGE , CHASE SMITH , JOACHIM VOGT
- Applicant: Forma Therapeutics, Inc.
- Applicant Address: US MA Watertown
- Assignee: Forma Therapeutics, Inc.
- Current Assignee: Forma Therapeutics, Inc.
- Current Assignee Address: US MA Watertown
- Priority: DEEP200601122344.2 20061016; USPCT/US2007/013299 20070606; IBPCT/IB2007/054209 20071016
- Main IPC: C07D471/04
- IPC: C07D471/04
![Pyrido-[2,3-D] Pyrimidines and Their Use as Kinase Inhibitors](/abs-image/US/2014/06/12/US20140163005A1/abs.jpg.150x150.jpg)
Abstract:
The present invention provides derivatives of pyrido[2,3-d]pyrimidin-7-one. These compounds are kinase inhibitors, including compounds that show anti-proliferative activity, including against tumor cells, and are useful in the treatment of diseases including cancer.
Information query
